top of page
Liquid Embolization Techniques for Treating Hypervascular Tumors with Dr. Resmi Charalel, Dr. Milan Patel, Dr. Venkatesh Krishnasamy on the BackTable VI Podcast
00:00 / 01:04
loading.gif

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 3  •  17 Jan 2025

Liquid Embolization Techniques for Treating Hypervascular Tumors

How do you devascularize a hypervascular tumor when the vessels feeding it are too small to catheterize? On this episode of BackTable Podcast, Dr. Kavi Krishnasamy is joined by Dr. Resmi Charalel and Dr. Milan Patel to walk through seven real-world cases where non-adhesive hydrogel liquid embolics made the difference. They break down patient selection, case planning, and how to deploy these agents for safe, efficient devascularization when traditional approaches fall short.

This podcast is supported by

Instylla

Timestamps

00:00 - Introduction
02:23 - Liquid Embolic Use in Practice
04:46 - Case 1: Renal Mass
07:51 - Delivery Technique and Target Vessel Size
13:08 - Device Setup and Catheter Compatibility
21:57 - Case 2: Multifocal HCC
27:44 - Case 3: Large Renal Tumor
40:21 - Randomized Trial Outcomes
43:28 - Case 4: HCC Near the Gallbladder
49:39 - Case 5: Pelvic Tumor and Femoral Metastases
55:30 - Lessons from Early Use and Case Selection
1:01:37 - Case 6: Breast Cancer Liver Metastasis
1:05:23 - Closing Remarks

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

The discussion reviews seven real-world cases, from renal and liver tumors to pelvic, bone, and breast metastases, sharing practical pearls on microcatheter selection, plug formation, controlled reflux, and navigating high-flow environments and multiple vessels. They dive into troubleshooting pitfalls like loose connections and procedural waste, the real learning curve for adopting liquid embolics, and the outcomes data that support broader adoption of these techniques. The episode closes with advice for early-career operators and a look at future directions for patients who are not candidates for other embolic therapies.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page